<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OCN-15006595</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2015-06-15</date_registration>
      <primary_sponsor>Southwest Hospital, Third Military Medical University</primary_sponsor>
      <public_title>Umbilical cord mesenchymal stem cells in the application of hematopoietic stem cell transplantation</public_title>
      <acronym />
      <scientific_title>Umbilical cord mesenchymal stem cells in the application of hematopoietic stem cell transplantation</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2015-07-01</date_enrolment>
      <type_enrolment />
      <target_size>1:70;2:70;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=11223</url>
      <study_type>Observational study</study_type>
      <study_design>Non randomized control</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Hematological malignancies</hc_freetext>
      <i_freetext>1:mesenchymal stem cells with hematopoietic stem cell transplantation  ;2:hematopoietic stem cell transplantation  ;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Li Xi</firstname>
        <middlename />
        <lastname />
        <address>Center for Hematology, SouthwestHospital, ThirdMilitary Medical University, 29 Gao Tanyan Street, Chongqing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15223038417</telephone>
        <email>lixi1988xn@163.com</email>
        <affiliation>SouthwestHospital, ThirdMilitaryMedical University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Chen Jieping</firstname>
        <middlename />
        <lastname />
        <address>Center for Hematology, SouthwestHospital, ThirdMilitary Medical University, 29 Gao Tanyan Street, Chongqing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13983766908</telephone>
        <email>chenjpxn@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged between 18 and 65 years;
2. KPS score &gt; 60 points and estimated survival time &gt; 3 months; 
3. With confirmed hematological malignancies and to be treated with hematopoietic stem cell transplantation;
4. Without serious mental illness and serious heart, liver, kidney or pulmonary insufficiency, and other fatal diseases; 
5. Agreed to participate in this study, and signed the informed consent form.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>65</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Serious mental patient; 
2. Serious heart, liver, kidney or pulmonary insufficiency; 
3. In gestation period or suckling period; 
4. HIV infection or substance abuse.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>disease-free survival;overall survival;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Graft implantation rate;Hematopoietic reconstruction rate;incidence of GVHD;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Southwest Hospital, Third Military Medical University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>1990-01-01</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>